secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phathom Pharmaceuticals, Inc. (PHAT)
CIK:        0001783183
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001193125-24-032946
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Express Scripts adds VOQUEZNA to national formularies for commercial plans
--------------------------------------------------------------------------

- Express Scripts, a leading U.S. PBM, added VOQUEZNA to its national formularies for commercial plans, effective immediately.
- Formulary placement offers access to VOQUEZNA with a single step through a generic proton pump inhibitor (PPI).
- Expanded formulary access may drive uptake of Phathom's approved product VOQUEZNA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783183/000119312524032946/0001193125-24-032946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783183/000119312524032946/d784856d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-032946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer